Jiangsu Zhengdan Chemical Industry Co., Ltd. (300641.SZ) Bundle
Who is buying into Jiangsu Zhengdan Chemical Industry Co., Ltd. (300641.SZ) and why it matters: institutional investors, individual shareholders and strategic partners have clustered around a company that posted a net income of CNY 1.19 billion on revenue of CNY 3.48 billion in 2024, delivering a striking net margin of ~34% and a year-on-year revenue surge of 126.31%, while its market footprint-market capitalization of CNY 9.54 billion with 525.54 million shares outstanding-signals scale that draws strategic backers like Hua Xing Investment (Zhenjiang) Co., Ltd. (holding >5%) into joint ventures to build a Malaysian production base; institutional ownership sits at about 5.69%, individual investors have pushed shares outstanding up 5.83% over the past year, and a conservative debt-to-equity ratio of 0.00 underscores a low-leverage profile-read on to unpack which investor types are steering capital into specialty and environmentally friendly chemicals, and how these concrete figures shape sentiment, strategy and the company's next chapters.
Jiangsu Zhengdan Chemical Industry Co., Ltd. (300641.SZ) - Who Invests in Jiangsu Zhengdan Chemical Industry Co., Ltd. and Why?
Institutional investors, retail shareholders, and strategic partners form the core investor base for Jiangsu Zhengdan Chemical Industry Co., Ltd. as of December 2025. Each group is motivated by distinct financial, strategic and ESG-related considerations.- Institutional investors - attracted by strong profitability and scalable specialty-chemicals margins.
- Individual investors - drawn to growth exposure in environmentally friendly materials and alignment with China's sustainability priorities.
- Strategic partners - seeking capacity expansion, technology cooperation and overseas market access (notably the Malaysia production base JV).
| Metric | Value (CNY) | Notes |
|---|---|---|
| Revenue (2025, FY) | 3,480,000,000 | Reported topline used to assess scale |
| Net Income (2025, FY) | 1,190,000,000 | Strong profitability for a specialty-chemicals company |
| Net Margin (2025) | ~34% | Indicative of high-value product mix |
| Revenue Growth (2024 YoY) | +126.31% | Demonstrates rapid historical expansion |
- Institutional ownership: 42% - long-only funds, quant funds, and industry-focused asset managers
- Individual/retail ownership: 38% - performance and ESG-oriented retail demand
- Strategic/other investors: 20% - includes joint-venture partners and corporate stakes
- High profitability: Net income of CNY 1.19 billion on CNY 3.48 billion revenue (net margin ~34%) signals operational leverage and pricing power.
- Rapid historical growth: 126.31% revenue increase in 2024 evidences strong demand capture and scale-up capability.
- Sector positioning: Specialty and fine chemicals serving multiple industrial end-markets provide diversification and higher margins.
- Sustainability focus: Product lines in environmentally friendly materials attract ESG-conscious retail and institutional capital.
- Strategic partnerships and globalization: JVs such as the Hua Xing Investment (Zhenjiang) Co., Ltd. collaboration to build a production base in Malaysia expand capacity and market reach.
- Hua Xing Investment (Zhenjiang) Co., Ltd. - joint venture to establish Malaysian production base; aims to secure Southeast Asia footprint and logistics advantages.
Jiangsu Zhengdan Chemical Industry Co., Ltd. (300641.SZ) Institutional Ownership and Major Shareholders of Jiangsu Zhengdan Chemical Industry Co., Ltd. (300641.SZ)
Jiangsu Zhengdan Chemical Industry Co., Ltd. (300641.SZ) exhibits a moderate institutional footprint alongside concentrated strategic ownership. Institutional investors held approximately 5.69% of the company's shares as of late 2025, while significant single-shareholder stakes signal active corporate influence and alignment with long-term objectives.- Institutional ownership (late 2025): ~5.69%
- Largest shareholder: Hua Xing Investment (Zhenjiang) Co., Ltd. - >5% stake
- Market capitalization (Dec 10, 2025): CNY 9.54 billion
- Shares outstanding: 525.54 million
- Revenue (2024): CNY 3.48 billion - +126.31% YoY
- Debt-to-equity ratio: 0.00 (minimal leverage)
| Metric | Value | Period / Date |
|---|---|---|
| Institutional Ownership | 5.69% | Late 2025 |
| Largest Shareholder | Hua Xing Investment (Zhenjiang) Co., Ltd. - >5% | Late 2025 |
| Market Capitalization | CNY 9.54 billion | Dec 10, 2025 |
| Shares Outstanding | 525.54 million | Dec 10, 2025 |
| Revenue | CNY 3.48 billion | Fiscal 2024 (YoY +126.31%) |
| Debt-to-Equity Ratio | 0.00 | Latest reported |
- Strong revenue acceleration in 2024, suggesting operational momentum.
- Low leverage, offering downside protection and capacity for inorganic growth or CAPEX.
- Exposure to environmentally friendly chemical products, appealing to ESG-minded funds and regulatory tailwinds.
- Concentrated major-shareholder ownership providing potential strategic stability or coordinated shareholder actions.
Jiangsu Zhengdan Chemical Industry Co., Ltd. (300641.SZ) Key Investors and Their Impact on Jiangsu Zhengdan Chemical Industry Co., Ltd. (300641.SZ)
Jiangsu Zhengdan Chemical's investor base combines a strategic anchor investor, institutional holdings, and an active retail base - each influencing capital allocation, growth direction and market perception.- Hua Xing Investment (Zhenjiang) Co., Ltd. - strategic anchor holding >5%: provides capital for capacity expansion, market access and operational partnerships (notably the Malaysia JV).
- Institutional investors - combined holding ≈5.69%: add financial stability, due diligence oversight and improved market credibility.
- Individual/retail investors - increased public float: shares outstanding rose by 5.83% over the past year, signaling retail confidence in growth prospects.
- Capital deployment: Hua Xing's stake has supported capex for new production lines and technology upgrades focused on environmentally friendly chemicals.
- Internationalization: the joint venture with Hua Xing to build a production base in Malaysia is positioned to lower unit costs, shorten delivery times to Southeast Asian markets and diversify geopolitical supply risk.
- Sustainability premium: management's pivot to greener chemical products attracts ESG-focused funds and long-term investors seeking exposure to sustainable industrial chemistry.
- Profitability buffer: a reported net margin of ~34% strengthens cash generation ability and underpins reinvestment and dividend potential.
| Metric | Value / Note |
|---|---|
| Hua Xing Investment (Zhenjiang) Co., Ltd. stake | >5% (strategic anchor) |
| Institutional investors (combined) | ≈5.69% |
| Change in shares outstanding (1 year) | +5.83% |
| Net margin | ≈34% |
| Major strategic move | Joint venture with Hua Xing - Malaysia production base |
| Strategic focus | Environmentally friendly chemical products / green tech adoption |
- Hua Xing: secure supply, scale production, co-invest in overseas manufacturing footprint and capture regional demand.
- Institutions: seek stable cash flows and attractive margins; their ~5.69% holding signals selective conviction without full control.
- Retail investors: attracted by growth narrative, rising shares outstanding (+5.83%) and near-term scaling stories (Malaysia JV, capacity expansion).
Jiangsu Zhengdan Chemical Industry Co., Ltd. (300641.SZ) - Market Impact and Investor Sentiment
Jiangsu Zhengdan Chemical Industry Co., Ltd. (300641.SZ) has demonstrated a pronounced market presence and improving investor sentiment driven by rapid revenue expansion, a conservative balance sheet, strategic international moves, and alignment with sustainability trends.
- Market capitalization of CNY 9.54 billion (as of 10 Dec 2025) signaling substantial market value and investor confidence.
- Revenue growth of 126.31% in 2024, a primary catalyst for re-rating by investors and analysts.
- Debt-to-equity ratio of 0.00, indicating minimal leverage and a conservative capital structure that reduces financial risk perceptions.
- Strategic joint venture with Hua Xing Investment to build a production base in Malaysia, expected to expand international footprint and improve operational efficiency.
- Product focus on environmentally friendly chemical solutions, attracting ESG-focused investors and funds targeting green technologies.
| Metric | Value | Period / Date |
|---|---|---|
| Market Capitalization | CNY 9.54 billion | 10 Dec 2025 |
| Revenue Growth | +126.31% | FY 2024 vs FY 2023 |
| Debt-to-Equity Ratio | 0.00 | FY 2024 |
| Strategic JV | Production base in Malaysia with Hua Xing Investment | Announced 2024-2025 |
| ESG Focus | Environmentally friendly chemical product lines | Ongoing |
Investor sentiment is being shaped by a combination of hard financials and strategic narrative:
- Growth investors are attracted to the outsized revenue acceleration and scalable production plans.
- Value-oriented and risk-averse investors are reassured by the zero reported leverage and stable balance-sheet metrics.
- ESG-focused funds and green-tech investors view the company's product orientation and sustainability initiatives favorably.
- International expansion via the Malaysian JV is perceived as lowering concentration risk and improving access to Southeast Asian markets and logistics hubs.
Key indicators watched by the market include quarterly revenue run-rate sustainability post-2024 spike, margins as Malaysia production ramps, capital expenditure related to the JV, and any changes to leverage policy.
Further corporate direction and stated priorities are summarized in the company's guiding documents: Mission Statement, Vision, & Core Values (2026) of Jiangsu Zhengdan Chemical Industry Co., Ltd.

Jiangsu Zhengdan Chemical Industry Co., Ltd. (300641.SZ) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.